載入...
Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation: Assessment, Monitoring and Treatment Reversal
It is essential to prevent thromboembolic events in atrial fibrillation. The risks of thromboembolic and haemorrhagic events must be carefully assessed and weighed against one another, both in routine situations and in relation to invasive procedures. Vitamin K antagonists, until recently the first-...
Na minha lista:
| 發表在: | Eur Cardiol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Radcliffe Cardiology
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6159394/ https://ncbi.nlm.nih.gov/pubmed/30310459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2016:30:1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|